TrialSignal transduction and targeted therapy2025

Dual targeting PD-L1 and 4-1BB to overcome dendritic cell-mediated lenalidomide resistance in follicular lymphoma.

Zhong Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.